Product Information
FYCOMPA 0.5 MG/ML ORAL SUSP is a brand product labeled by Eisai Inc., priced at $4.4642 per ML under NDC 62856029038. Its NADAC has been published 359 times since May 22, 2019.
FDA first approved this application on Apr 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/mL
Manufacturer
Eisai Inc.NDC
62856029038
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
PERAMPANELApproval Type
New Drug (NDA)
FDA Application
NDA208277FDA Approved
4/29/2016
TE Code
AB
On Market Since
4/30/2016
Pharmacological Classes
Price Statistics
The NADAC for FYCOMPA 0.5 MG/ML ORAL SUSP has been published 359 times since May 22, 2019, and over the history we have for it it has risen 28.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4642 per ML |
|---|---|
| All-time high | $4.4770 (Jun 12, 2024) |
| All-time low | $3.4709 (May 22, 2019) |
| 52-week high | $4.4679 |
| 52-week low | $4.4639 |
| Median price | $4.0758 |
| Average price | $4.0676 |
| Largest weekly change | +6.0% (Jan 31, 2024) |
| Weeks tracked | 359 |
| Tracking since | May 22, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
-0.0%
1Y
-0.1%
3Y
+6.0%
5Y
+15.2%
All
+28.6%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FYCOMPA 0.5 MG/ML ORAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for FYCOMPA 0.5 MG/ML ORAL SUSP, manufactured by Eisai Inc., is $4.4642 per ML (NDC 62856029038), effective Apr 1, 2026.
How has the price of FYCOMPA 0.5 MG/ML ORAL SUSP changed over time?
Over the history we have for it, the NADAC for FYCOMPA 0.5 MG/ML ORAL SUSP has risen 28.6%. It has been tracked across 359 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for FYCOMPA 0.5 MG/ML ORAL SUSP?
Since May 22, 2019, the NADAC for FYCOMPA 0.5 MG/ML ORAL SUSP has ranged from a low of $3.4709 (May 22, 2019) to a high of $4.4770 (Jun 12, 2024), with a median of $4.0758 per ML.
Are there cheaper alternatives to FYCOMPA 0.5 MG/ML ORAL SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FYCOMPA 0.5 MG/ML ORAL SUSP, is $4.4587 per ML — about 0% below FYCOMPA 0.5 MG/ML ORAL SUSP.
Who manufactures FYCOMPA 0.5 MG/ML ORAL SUSP?
FYCOMPA 0.5 MG/ML ORAL SUSP (NDC 62856029038) is labeled by Eisai Inc., and CMS classifies it as a brand product.